poisar

Stocks · News reference

Leerink Partners Maintains Outperform on Johnson & Johnson, Lowers Price Target to $272

Benzinga Newsdesk

Leerink Partners analyst David Risinger maintains Johnson & Johnson (NYSE:JNJ) with a Outperform and lowers the price target from $276 to $272.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

JNJ
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. The Motley Fool Team

    Johnson & Johnson: 3 Key Takeaways for Long-Term Investors

    Johnson & Johnson raised its full-year sales outlook after Q3 2026 operational revenue grew 6%, putting the company on track to exceed $100 billion in annual revenue for the first time. Strong pharmaceutical demand, particularly in cancer treatments, drove performance. However, the medical device segment faced headwinds with only 2.5% growth due to Middle East disruptions and China's bulk-buying program. Management plans to restore momentum through new product launches and is leaning toward spinning off its DePuy Synthes orthopedics subsidiary by mid-2027.

    JNJPFE
  3. Benzinga Insights

    9 Of 11 Sectors Rise In Friday Trading As Cyclicals Lead

    Nine of 11 sectors are higher in Friday’s regular session, with cyclical sectors holding the top three positions. The leaders are separated rather than clustered, with no single gap clearly standing apart from the other breaks across the table.

    APDAVGOBACBRKCOP
  4. Anthony Di Pizio

    This Unstoppable Vanguard ETF Could Turn $500 Per Month Into $1 Million Over the Long Term

    The Vanguard S&P 500 Growth ETF (VOOG) tracks the S&P 500 Growth index of 151 best-performing growth stocks, heavily weighted toward AI and technology companies. With a 16.9% compound annual return since 2010 and 28.4% over the last three years, consistent $500 monthly investments could potentially reach $1 million in approximately 23 years, even at conservative 14.1% annual returns.

    VOOGNVDAMSFTAAPLGOOG